PFIZER, INC.

PFE
Delayed Quote. Delayed  - 12/07 04:10:00 pm
51.72USD +0.47%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Number of employees : 78 500 people.
Sales per Business
2020
Oncology10 867.0025.9%
Internal Medicine9 003.0021.5%
Hospital7 961.0019%
Vaccines6 575.0015.7%
Inflammation & Immunology4 567.0010.9%
Rare Disease2 936.007%
USD in Million
Sales per region
20192020
United States23 852.0046.1%21 712.0051.8%
Developed Europe8 701.0016.8%7 788.0018.6%
Emerging Markets8 075.5015.6%5 857.5214%
Japan4 140.008%2 514.486%
China4 657.509%2 514.486%
Developed Rest of World2 325.004.5%1 521.523.6%
USD in Million
Managers
Name Title
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Aida Habtezion Chief Medical Officer
Rady A. Johnson Executive VP, Chief Compliance & Risk Officer
Suzanne Nora Johnson Independent Director
Helen H. Hobbs Independent Director
Shantanu Narayen Lead Independent Director
Shareholders
Name Equities %
The Vanguard Group, Inc. 436,283,399 7.78%
SSgA Funds Management, Inc. 279,803,181 4.99%
Capital Research & Management Co. (World Investors) 241,360,858 4.30%
Wellington Management Co. LLP 220,948,772 3.94%
Capital Research & Management Co. 142,320,700 2.54%
BlackRock Fund Advisors 120,282,008 2.15%
Geode Capital Management LLC 99,593,093 1.78%
Northern Trust Investments, Inc.(Investment Management) 67,839,011 1.21%
Norges Bank Investment Management 60,296,992 1.08%
State Farm Investment Management Corp. 53,568,997 0.96%
Company contact information
235 Street East 42nd
NY 10017 New York City, New York


Phone : +1 212 573 2323
Fax : +1 212 573 7851
web site : http://www.pfizer.com
Markets and indexes
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  PFIZ11B:BZ
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
PFIZER INC.52.71%288 950
JOHNSON & JOHNSON3.53%428 955
ROCHE HOLDING AG17.23%322 390
PFIZER, INC.44.09%288 950
NOVO NORDISK A/S65.08%245 091
ELI LILLY AND COMPANY45.45%223 321
ABBVIE INC.10.92%214 532
MERCK & CO., INC.-10.24%185 455
NOVARTIS AG-10.78%180 397
ASTRAZENECA PLC14.19%171 675
BRISTOL-MYERS SQUIBB COMPANY-8.38%126 142
SANOFI7.18%119 412
AMGEN INC.-9.19%117 604
GLAXOSMITHKLINE PLC15.86%103 178
CHUGAI PHARMACEUTICAL CO., LTD.-34.07%51 127
BAYER AG-7.41%49 398
JIANGSU HENGRUI MEDICINE CO., LTD.-45.98%49 252
DAIICHI SANKYO COMPANY, LIMITED-23.07%45 122
TAKEDA PHARMACEUTICAL COMPANY LIMITED-16.11%42 403
ASTELLAS PHARMA INC.11.73%28 823
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY34.74%22 355
Brand Portfolio
PFIZER
PFIZER
AMPLYX
AMPLYX
ARRAY BIOPHARMA
ARRAY BIOPHARMA
THERACHON
THERACHON
THERMACARE
THERMACARE
» More brands of Pfizer, Inc.